Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 550 of 672 entries
View as:

Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women

Phase: N/A Priority: Normal
NCT ID: NCT01705574 Org: User:
Start: 10/24/12 End: 09/06/18 Due: 09/06/19

Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT02135614 Org: User:
Start: 06/09/14 End: 04/12/17 Due: 04/12/18

Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant

Phase: N/A Priority: Normal
NCT ID: NCT02781571 Org: User:
Start: 07/27/16 End: 07/28/17 Due: 07/28/18

Phase I Study of Milatuzumab for Graft Versus Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT01663766 Org: User:
Start: 12/31/13 End: 03/31/15 Due: 03/31/16

Study to Evaluate the Effects of MBX-8025 in Patients With HoFH

Phase: N/A Priority: Normal
NCT ID: NCT02472535 Org: User:
Start: 04/30/15 End: 02/29/16 Due: 02/28/17

Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03964727 Org: User:
Start: 10/15/19 End: 09/30/25 Due: 09/30/26

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China)

Phase: N/A Priority: Normal
NCT ID: NCT02836236 Org: User:
Start: 06/19/15 End: 09/18/23 Due: 09/18/24

Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

Phase: N/A Priority: Normal
NCT ID: NCT03053063 Org: User:
Start: 01/30/17 End: 05/06/19 Due: 05/06/20

Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT02175758 Org: User:
Start: 07/07/14 End: 09/13/18 Due: 09/13/19

Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.

Phase: N/A Priority: Normal
NCT ID: NCT00158821 Org: User:
Start: 03/31/00 End: 06/30/13 Due: 06/30/14

Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant

Phase: N/A Priority: Normal
NCT ID: NCT01938430 Org: User:
Start: 09/30/13 End: 03/31/15 Due: 03/31/16

A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection

Phase: N/A Priority: Normal
NCT ID: NCT00736190 Org: User:
Start: 08/31/08 End: 07/31/10 Due: 07/31/11

Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01631552 Org: User:
Start: 12/17/12 End: 08/13/20 Due: 08/13/21

A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-6620 in Treatment Naïve Subjects With Chronic Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT01316237 Org: User:
Start: 01/31/11 End: 01/31/12 Due: 01/31/13

Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01980888 Org: User:
Start: 02/05/14 End: 06/16/16 Due: 06/16/17

Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01375036 Org: User:
Start: 08/31/11 End: 12/31/16 Due: 12/31/17

Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT04925752 Org: User:
Start: 06/28/21 End: 05/31/28 Due: 05/31/29

Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection

Phase: N/A Priority: Normal
NCT ID: NCT00445146 Org: User:
Start: 02/28/07 End: 03/31/15 Due: 03/31/16

Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)

Phase: N/A Priority: Normal
NCT ID: NCT02404220 Org: User:
Start: 05/06/15 End: 12/17/18 Due: 12/17/19

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting

Phase: N/A Priority: Normal
NCT ID: NCT02350569 Org: User:
Start: 05/22/15 End: 04/22/16 Due: 04/22/17

Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06532565 Org: User:
Start: 07/26/24 End: 06/30/28 Due: 06/30/29

Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT01858766 Org: User:
Start: 04/30/13 End: 08/31/14 Due: 08/31/15

A Prospective, Observational, Drug Utilization Study of Subjects Taking Truvada for Pre-exposure Prophylaxis in the USA

Phase: N/A Priority: Normal
NCT ID: NCT01865799 Org: User:
Start: 04/22/13 End: 01/22/18 Due: 01/22/19

Expanded Access Program for Aztreonam Lysine for Inhalation in Canadian Patients With Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT00989807 Org: User:
Start: - End: - Due: -

Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT01277601 Org: User:
Start: 04/30/11 End: 07/31/15 Due: 07/31/16